Gepotidacin: a novel, oral, ‘first-in-class’ triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea
Article in Journal of Antimicrobial Chemotherapy (March 2023)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)
Article in Antimicrobial Agents and Chemotherapy (March 2023)
Diminishing hERG inhibitory activity of aminopiperidine-naphthyridine linked NBTI antibacterials by structural and physicochemical optimizations
Article in Bioorganic Chemistry (August 2022)